1.Surgical treatment of acetabular fracture.
Chang Uk CHOI ; Byung Il LEE ; Byung Joon SHIN ; You Sung SUH ; Joo Hwan OH
The Journal of the Korean Orthopaedic Association 1992;27(3):763-773
No abstract available.
Acetabulum*
2.Apoptosis of Murine Macrophage-like Cells Infected with Orientia tsutsugamushi.
Nam Jong CHOI ; Mee Kyung KIM ; Heon Joo PARK ; Byung Uk LIM ; Jae Seung KANG
Journal of the Korean Society for Microbiology 1998;33(4):399-406
A large number of bacterial pathogens have been identified as mediators of apoptosis in vitro and the induction of apoptosis might be an important step in the pathogenesis of these bacteria. In this study, we analyzed the interactions of Orientia tsutsugamuchi with J774 murine macrophage-like cells. The J774 cells were infected with Boryong strain of O. tsutsugamushi and the DNA was analyzed with agarose gel electrophoresis. We observed the typical laddering pattern of DNA fragmentation indicative of apoptosis in infected cells but not cells infected with heat-killed O. tsutsugamushi. We performed terminal deoxynucleotidyl transferase (TdT) assay to label the 3'-hydroxy ends of DNA breaks and observed intense brown staining of nuclei of infected macrophages. With Hoechst 33258 for staining nucleus, strong chromatin condensation was observed only in infected J774 cells. We also examined the cytokine secretion pattern of J774 cells during the rickettsial infection. The large amount of TNF-alpha and IL-10 were secreted after 24 hrs of infection, but the secretion of IL-1beta was increased in small amount. These results showed that O. tsutsugamushi induce apoptosis in murine macrophage-like cells by different mechanism from that of shigella which cause secretion of large amount of IL-1beta.
Apoptosis*
;
Bacteria
;
Bisbenzimidazole
;
Chromatin
;
Chungcheongnam-do
;
DNA
;
DNA Breaks
;
DNA Fragmentation
;
DNA Nucleotidylexotransferase
;
Electrophoresis, Agar Gel
;
Interleukin-10
;
Macrophages
;
Orientia tsutsugamushi*
;
Shigella
;
Tumor Necrosis Factor-alpha
3.The Effect of THAM and Sodium Bicarbonate on the Gut Mucosa Oxygenation following Hemorrhagic Shock in Cats.
Soo Joo CHOI ; In Cheol CHOI ; Jeoung Uk KIM ; Sam Soon CHO ; Pyung Hwan PARK ; Byung Te SUH
Korean Journal of Anesthesiology 1996;31(4):418-426
BACKGROUND: In hypovolemic shock, multiple organ failure is caused by translocation of endotoxins and microorganisms from the ischemic gut mucosa. Therefore, much attention has been paid to the gut mucosa oxygenation in shock resuscitation. The current guidelines on cardiopulmonary resuscitation restrain the use of sodium bicarbonate due to paradoxical intracellular acidosis. Because THAM, CO2-consuming agent, does not produce CO2 and induce intracellular acidosis, THAM has been known as a effective buffering agent. This study was purposed to investigate the effect of THAM and sodium bicarbonate on the gut mucosa oxygenation in cats which were in hemorrhagic shock and resuscitation. METHODS: 18 anesthetized cats were subjected to hemorrhage to decrease the mean arterial blood pressure to 35-45 mmHg and this blood pressure was maintained for 120 minutes. After 90minutes, we infused 1.945% hypertonic saline, 2.8% sodium bicarbonate and 0.3M THAM as same volume and osmolality. Mean arterial pressure(MAP), mesenteric arterial-venous pH differences[pH(a-v)], mesenteric venous oxygen tension(PvO2), mesenteric arterial-venous carbon dioxide tension differences[P(v-a)CO2], mesenteric arterial-venous lactate differences[Lactate(v-a)] were measured 1, 5, 15, 30 minutes after drug infusion and 30, 60 minutes after reperfusion. RESULTS: There were no statistical significances in MAP, pH(a-v), PvO2, Lactate(v-a) among the three groups. There were significant differences in P(v-a)CO2 and ETCO2 between sodium bicarbonate group and THAM group. CONCLUSIONS: This study suggest that THAM and sodium bicarbonate do not have significant effects on the tissue oxygenation and hemodynamic improvement in hypovolemic shock. We suppose that THAM does not produce carbon dioxide but may correct intracellular acidosis.
Acidosis
;
Animals
;
Arterial Pressure
;
Blood Pressure
;
Carbon Dioxide
;
Cardiopulmonary Resuscitation
;
Cats*
;
Endotoxins
;
Hemodynamics
;
Hemorrhage
;
Hydrogen-Ion Concentration
;
Lactic Acid
;
Mucous Membrane*
;
Multiple Organ Failure
;
Osmolar Concentration
;
Oxygen*
;
Reperfusion
;
Resuscitation
;
Shock
;
Shock, Hemorrhagic*
;
Sodium Bicarbonate*
;
Sodium*
;
Tromethamine*
4.Effect of Vortioxetine on Alcohol Intake in C57BL/6 Mice
Se Ra CHOI ; Ji-Woon JEONG ; Sung Young HUH ; Byung-Uk JOO ; Hyeon-Kyeong KIM ; Sung-Gon KIM
Journal of the Korean Society of Biological Therapies in Psychiatry 2023;29(3):87-92
Objectives:
The effectiveness of drugs currently used in medication, which is important in the treatment of alcohol use disorders, is limited. Recently, ondansetron which acts as 5-HT3 receptor antagonist, has been studied and proved possibility as new medication for alcohol use disorder. Meanwhile, there are studies supporting that 5-HT1A receptors are related to addictive behavior. Considering those studies, we expect that vortioxetine, which acts as both 5-HT3 receptor antagonist and 5-HT1A receptor agonist, may be effective in treatment of alcohol use disorder. The purpose of this study is to examine the effect of vortioxetine on alcohol intake of C57BL/6 mice.
Methods:
In this study C57BL/6 mice were randomly assigned to normal saline group, vortioxetine 10 mg/kg group and vortioxetine 1 mg/kg group. To study effect of vortioxetine on alcohol, water, food intake and body weight of mice, we administered each medication for 14 days.
Results:
The overall alcohol intake was different between the three groups (PGroup=0.021), and alcohol intake in vortioxetine 10 mg/kg group was significantly lower than one in placebo group. Change across time points (PTime<0.001) and the interaction between group and time (PGroup×Time =0.016) were also significant. However, there were no significant differences between the three groups in water, food intake and body weight.
Conclusions
These results indicated that administration of high dose vortioxetine reduced alcohol intake of mice.Therefore, it is necessary to conduct clinical studies to examine the effectiveness of vortioxetine as a new treatment for alcohol use disorder.
5.The difference of heart rate recovery in ischemic heart disease comparing to normal.
Dong Uk JU ; Hyun Jae KANG ; Sun Wung KIM ; Tae Mook NO ; Hyuk Su SON ; Byung Jun KANG ; Sae Rom KIM ; Bong Ryeol LEE ; Byung Chun JUNG ; Jong Joo LEE
Korean Journal of Medicine 2004;66(6):586-592
BACKGROUND: The goal of this study is to evaluate the differences of the rate and the ratio of heart rate changes, which is well known to reflect the vagal reactivation, after peak exercise between ischemic heart disease and normal during treadmill exercise test. Additionally R-wave amplitude changes are evaluated to have the discriminal power between ischemic heart disease and normal. METHODS: We have studied 253 human (196 control, 57 patients) who took the symptom-limited exercise test using Marquette case 8000 model. The 57 patients who showed the positive result by exercise test have confirmed by coronary angiography. The rate of heart rate changes was defined as the absolute difference of the heart rate subtracted by the just-previous stage heart rate. The ratio of heart rate changes was defined as the percentile of the rate of heart rate changes comparing to the just-previous stage heart rate. The changes of R-wave amplitude at lead V5 and aVF were obtained by the subtraction of R-wave amplitude at the peak exercise stage from that at the standing rest stage respectively. Additively heart rate recovery was defined as the rate of heart rate change which was obtained at 1 minute later after peak exercise. RESULTS: In patients and control, the resting heart rate were 70 +/- 13 bpm and 69 +/- 11 bpm (p>0.05), and the peak heart rate were 136 +/- 22 bpm and 155 +/- 18 bpm respectively (p<0.001). The rate of heart rate changes in patients group were significantly lower than that in control at 1 minute, 3 minute, and 5 minute respectively (p<0.001, p=0.008, p=0.002). The ratio of heart rate changes in patients group were also significantly lower than that in control at 1 minute, 3 minute, and 5 minute respectively (p=0.017, p=0.027, p=0.002). With comparing both groups, the incidences of ventricular ectopy were not different during exercise and recovery stages, and the difference in the changes of R-wave amplitude at lead V5 and aVF were not observed respectively. CONCLUSION: The rate and ratio of heart rate changes are significantly lower in iscemic heart disease than in normal, and these are resulted from the depression of vagal reactivation. These findings are supplemental to make a diagnosis and a arrhythmic risk stratification of ischemic heart disease.
Coronary Angiography
;
Depression
;
Diagnosis
;
Exercise Test
;
Heart Diseases
;
Heart Rate*
;
Heart*
;
Humans
;
Incidence
;
Myocardial Ischemia*
6.Synergistic Effect of Ionizing Radiation and beta-lapachone against RKO Human Colon Adenocarcinoma Cells.
Eun Jung KIM ; In Mi JI ; Ki Jung AHN ; Eun Kyung CHOI ; Heon Jin PARK ; Byung Uk LIM ; Chang W SONG ; Heon Joo PARK
Cancer Research and Treatment 2005;37(3):183-190
PURPOSE: To reveal the interaction between beta-Lapachone (beta-lap) and ionizing radiation in causing cell death in RKO human colon adenocarcinoma cells, and to elucidate the potential usefulness of combined beta-lap treatment and radiotherapy for cancer treatment. MATERIALS AND METHODS: The cytotoxicities of various treatments were determined in vitro using clonogenic and apoptotic cell death. The changes in cell cycle distribution were studied using flow cytometry and an in vitro kinase assay. The tumor growth was studied using RKO tumors grown s.c. in the hind leg BALB/c- nuslc nude mice. RESULTS: beta-lap caused clonogenic cell death and rapid apoptosis in RKO cells in vitro, in a dose dependent manner. The repair of sublethal radiation damage was almost completely inhibited when cells were maintained in beta-lap during the interval between the two-dose irradiation. Flow cytometry study demonstrated that beta-lap induced apoptosis, independent of the cell cycle phase, and completely prohibited the induction of radiation- induced G2 arrest in irradiated cells. The prohibition of radiation-induced G2 arrest is unclear, but may be related to the profound suppression of the p53, p21 and cyclin B1-Cdc2 kinase activities observed in cells treated with beta-lap. The combination of beta-lap and radiation markedly enhanced the radiation-induced growth suppression of tumors. CONCLUSION: beta-lap is cytotoxic against RKO cells, both in vitro and in vivo, and also sensitized cells to ionizing radiation by inhibiting sublethal radiation damage repair. beta-lap is potentially useful as a potent anti-cancer chemotherapy drug and potent radiosensitizer against caner cells.
Adenocarcinoma*
;
Animals
;
Apoptosis
;
Cell Cycle
;
Cell Death
;
Colon*
;
Cyclins
;
Drug Therapy
;
Flow Cytometry
;
Humans*
;
Leg
;
Mice
;
Mice, Nude
;
Phosphotransferases
;
Radiation, Ionizing*
;
Radiotherapy
7.EVAR with Aortouniiliac Stent Graft and Converter in a Patient with AAA andIliac Artery Occlusion.
Sung Uk BAE ; Byung Sun CHO ; Young Jin CHOI ; Min Koo LEE ; Sung Hye PARK ; Chang Nam KIM ; Yoon Jung KANG ; Joo Seung PARK
Journal of the Korean Society for Vascular Surgery 2008;24(1):49-51
Endovascular aneurysm repair (EVAR) has become increasingly popular since Parodi reported the first endovascular repair in 1991. Aortobiiliac stent grafting has gained popularity as an endovascular technique for managing abdominal aortic aneurysms (AAA), but the use of aortouniiliac stenting with femorofemoral bypass increases the proportion of patients treatable by endovascular techniques. The Zenith AAA Endovascular Graft Converter is used to convert a bifurcated graft to an aortouniiliac graft. We report successful EVAR using an aortouniiliac stent graft and converter in a 66-year-old man with an AAA and right common iliac artery occlusion. The preoperative CT angiography showed an infrarenal AAA 78 mm in diameter and right common iliac artery occlusion with recanalization by a collateral epigastric artery. The converter was deployed after placement of the main body, and the iliac leg extension was placed in the left external iliac artery. No postoperative complications occurred, and no endoleak was seen on follow-up CT angiography.
Aged
;
Aneurysm
;
Angiography
;
Aortic Aneurysm, Abdominal
;
Arteries
;
Endoleak
;
Endovascular Procedures
;
Epigastric Arteries
;
Follow-Up Studies
;
Humans
;
Iliac Artery
;
Leg
;
Postoperative Complications
;
Stents
;
Transplants
8.A Case of Complete Agenesis of the Dorsal Pancreas.
Sun Jung KIM ; Byung Hoon HAN ; Hyun Joo JUNG ; Hong Jun YOU ; Sung Woo YANG ; Se Young PARK ; Sang Uk LEE
Korean Journal of Gastrointestinal Endoscopy 2008;36(4):252-256
The pancreas with the complete absence of its body and tail is the result of underdevelopment or agenesis of the dorsal pancreatic bud during embryogenesis, and this is a rare anomaly. We report here on a case of a 38-year-old man who had a pancreas with the total absence of the body and tail. On the abdominal computed tomography (CT), only a pancreatic head portion with speckled calcifications was seen, and the pancreatic body and tail were not visualized at all. Endoscopic retrograde cholangiopancreatography (ERCP) showed only a short major pancreatic duct with smooth tapering and terminal arborization. The Ampulla of Vater had a normal appearance and it was located at the medial side of the second portion of the duodenum. There was no difficulty to perform cannulation. Any minor papilla was not found. On magnetic resonance cholangiopancreatography (MRCP), the duct of Santorini and the duct in the body and tail were not visualized.
Adult
;
Ampulla of Vater
;
Catheterization
;
Cholangiopancreatography, Endoscopic Retrograde
;
Cholangiopancreatography, Magnetic Resonance
;
Congenital Abnormalities
;
Duodenum
;
Embryonic Development
;
Female
;
Head
;
Humans
;
Pancreas
;
Pancreatic Ducts
;
Pregnancy
9.Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?.
Byung Cheol SONG ; Yoo Kyung CHO ; Hyeyoung JWA ; Eun Kwang CHOI ; Heung Up KIM ; Hyun Joo SONG ; Soo Young NA ; Sun Jin BOO ; Seung Uk JEONG
Clinical and Molecular Hepatology 2014;20(4):355-360
BACKGROUND/AIMS: Spontaneous HBeAg seroconversion occurs frequently in the immune reactive phase in HBeAg-positive chronic hepatitis B (CHB). Therefore, observation for 3-6 months before commencing antiviral therapy is recommended in patients with alanine aminotransferase (ALT) levels that exceed twice the upper limit of normal (ULN). However, HBeAg seroconversion occurs infrequently in patients infected with hepatitis B virus (HBV) genotype C. The aim of the present study was to determine whether the waiting policy is necessary in endemic areas of HBV genotype C infection. METHODS: Ninety patients with HBeAg-positive CHB were followed prospectively without administering antiviral therapy for 6 months. Antiviral therapy was initiated promptly at any time if there was any evidence of biochemical (i.e., acute exacerbation of HBV infection or aggravation of jaundice) or symptomatic deterioration. After 6 months of observation, antiviral therapy was initiated according to the patient's ALT and HBV DNA levels. RESULTS: Only one patient (1.1%) achieved spontaneous HBeAg seroconversion. Biochemical and symptomatic deterioration occurred before 6 months in 17 patients (18.9%) and 5 patients, respectively. High ALT and HBV DNA levels were both independent risk factors for biochemical deterioration. Of 15 patients with HBV DNA > or =5.1x107 IU/mL and ALT > or =5xULN, biochemical deterioration occurred in 7 (46.7%), including 1 patient receiving liver transplantation due to liver failure. CONCLUSIONS: Spontaneous HBeAg seroconversion in patients with HBeAg-positive CHB is rare within 6 months. Biochemical deterioration was common and may lead to liver failure. Immediate antiviral therapy should be considered, especially in patients with high ALT and HBV DNA levels in endemic areas of genotype C infection.
Adult
;
Alanine Transaminase/blood
;
Antiviral Agents/*therapeutic use
;
DNA, Viral/blood
;
Female
;
Follow-Up Studies
;
Genotype
;
Guanine/analogs & derivatives/therapeutic use
;
Hepatitis B e Antigens/*blood
;
Hepatitis B virus/*genetics
;
Hepatitis B, Chronic/*drug therapy
;
Humans
;
Male
;
Middle Aged
;
Prospective Studies
;
Risk Factors
10.Effect of Dominant Hand Paralysis on Quality of Life in Patients With Subacute Stroke.
Hyeon Uk NAM ; Jin Seok HUH ; Ji Na YOO ; Jong Moon HWANG ; Byung Joo LEE ; Yu Sun MIN ; Chul Hyun KIM ; Tae Du JUNG
Annals of Rehabilitation Medicine 2014;38(4):450-457
OBJECTIVE: To evaluate the degree to which the paralysis of a dominant hand affects quality of life (QOL) in patients with subacute stroke. METHODS: We recruited 75 patients with subacute hemiplegic stroke. Patients were divided into two groups according to the location of the lesion and the side of the dominant hand. Group 1 consisted of patients whose strokes affected the dominant hand (i.e., right hemiplegia and right dominant hand or left hemiplegia and left dominant hand). Group 2 consisted of patients whose strokes affected the non-dominant hand (i.e., left hemiplegia and right dominant hand or right hemiplegia and left dominant hand). The primary outcome measure was the Short-Form 36-Item Health Survey (SF-36), which was used to evaluate health-related QOL. Secondary outcomes were scores on the Modified Barthel Index (MBI) and Beck Depression Inventory (BDI). RESULTS: We did not find any statistically significant differences between the groups in any SF-36 domain including the summaries of physical and mental component. Similarly, the MBI and BDI scores were not significantly different between the groups. CONCLUSION: The effect of paralysis on the dominant hand and QOL in patients with subacute stroke was not significantly different from the effect of paralysis on the non-dominant hand.
Depression
;
Hand*
;
Health Surveys
;
Hemiplegia
;
Humans
;
Outcome Assessment (Health Care)
;
Paralysis*
;
Quality of Life*
;
Stroke*